Verkazia recommended for use in Quebec

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Institut National D’excellence en Santé et en Services Sociaux in Quebec has recommended the inclusion of Verkazia eye drops on the lists of drugs for the treatment of severe vernal keratoconjunctivitis, Santen Canada announced in a press release.

Verkazia (cyclosporine 0.1% topical ophthalmic emulsion) is indicated for the treatment of the rare and potentially debilitating ocular allergic disease in children ages 4 years through adolescence.

The recommendation allows the drug formulation to move toward being available to patients in Quebec.